Stock Information
Praxis Precision Medicines Inc (PRAX)
Ticker Symbol: PRAX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $7,761.73 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -13.4539
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -58.74%
Latest News
-
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1245 Price Target
Tue, Apr 7, 2026 7:01 AM
-
Praxis: Strong Buy As Relutrigine Submission Accepted Plus Expansion Potential
Mon, Apr 6, 2026 4:10 PM
-
BTIG Reiterates Buy on Praxis Precision Medicine, Maintains $843 Price Target
Mon, Apr 6, 2026 12:14 PM
-
Praxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In Trial
Mon, Apr 6, 2026 9:08 AM
-
Praxis Precision Medicines Reports Topline Results From The EMBRAVE Part A Trial Of Elsunersen In Pediatric Patients With Early-Seizure Onset SCN2A Developmental And Epileptic Encephalopathy; Cuts Seizures By ~77% In Rare Pediatric Epilepsy Trial, Shows Broad Developmental Gains With Clean Safety Profile
Mon, Apr 6, 2026 8:48 AM
Key Financials
Financial data not available
